Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
์ข
๋ชฉ ์ฝ๋ VTAK
ํ์ฌ ์ด๋ฆCatheter Precision Inc
์์ฅ์ผSep 27, 2018
CEOJenkins (David A)
์ง์ ์22
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃSep 27
์ฃผ์1670 Highway 160 West
๋์FORT MILL
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX โ NASDAQ Basic Amex
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ29708
์ ํ19736912000
์น์ฌ์ดํธhttps://www.ramed.com/
์ข
๋ชฉ ์ฝ๋ VTAK
์์ฅ์ผSep 27, 2018
CEOJenkins (David A)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์